(CNN) — AstraZeneca has booked its first profit from sales of its Covid-19 vaccine. A company spokesperson confirmed that AstraZeneca would continue to fulfill existing orders to developing countries at no profit, as previously pledged. Sales of its Covid-19 vaccine contributed to a rise in AstraZeneca's total revenues for the first nine months of the year, which were up by nearly a third to $25.4 billion. According to the company, supplying the Covid-19 at no profit to AstraZeneca had contributed to a drop in core profit margin of six percentage points to 74.1%, alongside a rise in general expenses and research costs. This story was first published on CNN.com, "AstraZeneca is starting to profit from sales of its Covid-19 vaccine."

Source: CNN November 12, 2021 13:27 UTC